Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Eva Baroke"'
Autor:
Monika Eichinger, Karin Palmowski, Ute Oltmanns, Arne Warth, Michael Kreuter, Felix J.F. Herth, Claus Peter Heussel, Eva Baroke
Publikováno v:
Respirology. 21:191-194
PPFE is a rare disease characterized by upper lobe pleural fibrosis and parenchymal fibroelastosis. Its aetiology is considered idiopathic, although possible causative factors have been described. An association of PPFE with solid tumours is unknown
Autor:
W. Nikolaus Kühn-Velten, Julius J. Schmidt, Jan T. Kielstein, Ann-Kathrin Strunk, Eva Baroke, Olaf Wiesner
Publikováno v:
Clinical Nephrology. 84:104-107
Hemodialysis is the extracorporeal treatment of choice for various life-threatening intoxications, with the exception of highly protein-bound substances, which are preferably removed by charcoal hemoperfusion. This technique, however, is limited by i
Publikováno v:
Clinical Investigation. 1:1669-1680
Idiopathic pulmonary fibrosis (IPF) is an increasingly prevalent and devastating disease with high mortality and poor treatment options. Major advances in understanding its underlying pathogenesis have changed the traditional concept of IPF being a c
Autor:
Jens Martens-Lobenhoffer, Jan T. Kielstein, Stefanie M. Bode-Böger, Julius J. Schmidt, Ann-Kathrin Strunk, Tobias Welte, Eva Baroke
Publikováno v:
Journal of Antimicrobial Chemotherapy. 69:2008-2010
Sir, The emergence of multidrug-resistant bacteria has recently renewed interest in colistin, which was first introduced in 1959. For intravenous administration, not colistin itself, but its inactive prodrug colistin methanesulfonate (CMS) is adminis
Autor:
Michael Meister, Ute Oltmanns, Eva Baroke, Michael Kreuter, Nicolas Kahn, Martin Granzow, Ralf Eberhardt, Felix J.F. Herth, Thomas Muley
Publikováno v:
1.5 Diffuse Parenchymal Lung Disease.
Bronchoscopic Microsampling (BMS) of endobronchial epithelial lining fluid (EELF) might be a potent method for assessing novel molecular biomarkers to improve diagnostics and risk assessment in interstitial lung diseases. In contrast to BAL, EELF can
Autor:
Karin Palmowski, Ute Oltmanns, Felix J.F. Herth, Arne Warth, Nicolas Kahn, Eva Baroke, Michael Kreuter, Claus Peter Heussel
Publikováno v:
1.5 Diffuse Parenchymal Lung Disease.
Background: PPFE is a rare condition currently described as an upper lobe subpleural and interstitial proliferation of elastic fibers. Little is known about its etiology, which is mainly regarded as idiopathic. Although predisposing factors such as l
Autor:
Nicolas Kahn, U Oltmanns, M. Wiebel, Michael Kreuter, Felix J.F. Herth, Ralf Eberhardt, Marcus A. Mall, K Palmowski, Sabine Wege, Eva Baroke, Mark O. Wielpütz
Publikováno v:
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society. 15(2)
Background Chronic inflammation and remodeling of the airways remain a hallmark of cystic fibrosis (CF). However, knowledge of the associated mucosal micro-anatomical changes is limited. We evaluated the potential of optical coherence tomography (OCT
Publikováno v:
Expert review of respiratory medicine. 7(5)
Idiopathic pulmonary fibrosis (IPF) is a chronic progressive interstitial lung disease with increasing prevalence, high mortality rates and poor treatment options. The diagnostic process is complex and often requires an interdisciplinary approach bet
Autor:
Martin Kolb, Helen Bailey, Gisli Jenkins, Jack Gauldie, Shyam Maharaj, Andy Blanchard, Alycia Tenuta, Gauri Saini, Juliet Kay Simpson, Rebecca Braybrooke, Eva Baroke
Publikováno v:
B28. EMERGING BIOMARKERS OF COMPLEX LUNG DISEASES.
Publikováno v:
Pneumologie. 66